BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38608499)

  • 1. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm.
    Malekzadeh S; Cannella R; Fournier I; Hiroz P; Mottet C; Constantin C; Widmer L
    Eur J Radiol; 2024 Jun; 175():111455. PubMed ID: 38608499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
    D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
    Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
    Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
    Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed high-b-value high-resolution DWI improves solid lesion detection in IPMN of the pancreas.
    Harder FN; Jung E; Weiss K; Graf MM; Kamal O; McTavish S; Van AT; Demir IE; Friess H; Phillip V; Schmid RM; Lohöfer FK; Kaissis GA; Makowski MR; Karampinos DC; Braren RF
    Eur Radiol; 2023 Oct; 33(10):6892-6901. PubMed ID: 37133518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
    Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
    AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
    Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
    Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
    Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI.
    Hong GS; Byun JH; Kim JH; Kim HJ; Lee SS; Hong SM; Lee MG
    Eur Radiol; 2016 Sep; 26(9):3112-20. PubMed ID: 26694060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Preoperative Imaging for Differentiation of Branch Duct Versus Mixed Duct Intraductal Papillary Mucinous Neoplasms.
    Ugbarugba EE; Grieco C; Hart PA; Li F; Sklaw B; Cronley K; Oza VM; Swanson BJ; Walker JP; El-Dika S; Conwell DL; Krishna SG
    Pancreas; 2018; 47(5):556-560. PubMed ID: 29683969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.
    Hwang J; Kim YK; Min JH; Jeong WK; Hong SS; Kim HJ
    Eur Radiol; 2018 Jan; 28(1):179-187. PubMed ID: 28779397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.
    Castelli F; Bosetti D; Negrelli R; Di Paola V; Zantedeschi L; Ventriglia A; Manfredi R; Mucelli RP
    Radiol Med; 2013 Sep; 118(6):917-29. PubMed ID: 23801393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.